Title : c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.

Pub. Date : 2005 Jul 8

PMID : 15922853






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Receptor tyrosine kinase (RTK) targeted agents such as trastuzumab, imatinib, bevacizumab, and gefitinib inhibitors have illustrated the utility of targeting this protein class for treatment of selected cancers. Gefitinib ret proto-oncogene Homo sapiens
2 Receptor tyrosine kinase (RTK) targeted agents such as trastuzumab, imatinib, bevacizumab, and gefitinib inhibitors have illustrated the utility of targeting this protein class for treatment of selected cancers. Gefitinib ret proto-oncogene Homo sapiens